https://doi.org/10.1093/annonc/mdv548
A
Abdoulaye Karaboué
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
74
Papers
1.6K
Citations
22
h-index
28
i10-index
Abdoulaye Karaboué is an academic researcher from Université Paris-Saclay. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Cancer Treatment and Pharmacology & Hepatocellular Carcinoma Treatment and Prognosis. The author has an h-index of 22, co-authored 63 publications.
ORCID: 0000-0003-2074-2557Papers by this author
worksConversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV
2015 · Annals of Oncology · 145 citations
Effect of immunotherapy-infusion time of day on survival of patients with advanced cancers: a study-level meta-analysis
2024 · ESMO Open · 61 citations
https://doi.org/10.1016/j.esmoop.2023.102220
Why does circadian timing of administration matter for immune checkpoint inhibitors’ efficacy?
2024 · British Journal of Cancer · 51 citations
https://doi.org/10.1038/s41416-024-02704-9
Overall survival according to time-of-day of combined immuno-chemotherapy for advanced non-small cell lung cancer: a bicentric bicontinental study
2025 · EBioMedicine · 25 citations
https://doi.org/10.1016/j.ebiom.2025.105607
Circadian and chemotherapy-related changes in urinary modified nucleosides excretion in patients with metastatic colorectal cancer
2021 · Scientific Reports · 5 citations
https://doi.org/10.1038/s41598-021-03247-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat